• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性 EBV 感染后功能性抗体的演变。

Evolution of functional antibodies following acute Epstein-Barr virus infection.

机构信息

University of Duisburg-Essen, University Hospital Essen, Institute for Translational HIV Research; Essen, Germany.

Ragon Institute of MGH, MIT and Harvard; Cambridge, Massachusetts, United States of America.

出版信息

PLoS Pathog. 2022 Sep 6;18(9):e1010738. doi: 10.1371/journal.ppat.1010738. eCollection 2022 Sep.

DOI:10.1371/journal.ppat.1010738
PMID:36067220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9481173/
Abstract

While Epstein-Barr virus causes mostly asymptomatic infection, associated malignancies, and autoimmune and lymphoproliferative diseases occur. To dissect the evolution of humoral immune responses over the course of EBV infection and to gain a better understanding of the potential contribution of antibody (Ab) function to viral control, we comprehensively profiled Ab specificities and Fc-functionalities using systems serology and VirScan. Ab functions against latent (EBNA1), early (p47/54) and two late (gp350/220 and VCA-p18) EBV proteins were overall modest and/or short-lived, differing from humoral responses induced during acute infection by other viruses such as HIV. In the first year post infection, only p18 elicited robust IgM-driven complement deposition and IgG-driven neutrophil phagocytosis while responses against EBNA-1 were largely Fc-functionally silent and only matured during chronic infection to drive phagocytosis. In contrast, Abs against Influenza virus readily mediated broad Fc-activity in all participants. These data suggest that EBV evades the induction of robust Fc-functional Abs, potentially due to the virus' life cycle, switching from lytic to latent stages during infection.

摘要

虽然 Epstein-Barr 病毒主要引起无症状感染,但与之相关的恶性肿瘤、自身免疫和淋巴增生性疾病也会发生。为了剖析 EBV 感染过程中体液免疫反应的演变,并更好地了解抗体(Ab)功能对病毒控制的潜在贡献,我们使用系统血清学和 VirScan 全面分析了 Ab 的特异性和 Fc 功能。针对潜伏(EBNA1)、早期(p47/54)和两个晚期(gp350/220 和 VCA-p18)EBV 蛋白的 Ab 功能总体上较为温和和/或短暂,与 HIV 等其他病毒引起的急性感染时诱导的体液免疫反应不同。在感染后第一年,只有 p18 引发了强烈的 IgM 驱动的补体沉积和 IgG 驱动的中性粒细胞吞噬作用,而针对 EBNA-1 的反应在很大程度上是 Fc 功能沉默的,仅在慢性感染期间成熟以驱动吞噬作用。相比之下,流感病毒的抗体容易在所有参与者中介导广泛的 Fc 活性。这些数据表明,EBV 逃避了诱导强烈的 Fc 功能 Ab 的产生,这可能是由于病毒的生命周期,在感染过程中从裂解阶段转变为潜伏阶段。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/17f65dbb25b0/ppat.1010738.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/fa955832a19c/ppat.1010738.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/cd9dbd5e203b/ppat.1010738.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/9ca9df5a677d/ppat.1010738.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/b540f5ca02fa/ppat.1010738.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/2720177a9c25/ppat.1010738.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/f6b3aa9ff4e2/ppat.1010738.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/0c1bc31d0cb3/ppat.1010738.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/17f65dbb25b0/ppat.1010738.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/fa955832a19c/ppat.1010738.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/cd9dbd5e203b/ppat.1010738.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/9ca9df5a677d/ppat.1010738.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/b540f5ca02fa/ppat.1010738.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/2720177a9c25/ppat.1010738.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/f6b3aa9ff4e2/ppat.1010738.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/0c1bc31d0cb3/ppat.1010738.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a11d/9481173/17f65dbb25b0/ppat.1010738.g008.jpg

相似文献

1
Evolution of functional antibodies following acute Epstein-Barr virus infection.急性 EBV 感染后功能性抗体的演变。
PLoS Pathog. 2022 Sep 6;18(9):e1010738. doi: 10.1371/journal.ppat.1010738. eCollection 2022 Sep.
2
Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.以免疫荧光法为参考方法,评估Architect爱泼斯坦-巴尔病毒(EBV)病毒衣壳抗原(VCA)IgG、VCA IgM和EBV核抗原1 IgG化学发光免疫分析法用于检测EBV抗体及对EBV感染状态进行分类的情况。
Clin Vaccine Immunol. 2014 May;21(5):684-8. doi: 10.1128/CVI.00104-14. Epub 2014 Mar 12.
3
Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.评估 Architect EBV VCA IgM、VCA IgG 和 EBNA-1 IgG 化学发光免疫分析,以评估移植前的 EBV 血清状态。
J Med Virol. 2017 Nov;89(11):2003-2010. doi: 10.1002/jmv.24889. Epub 2017 Aug 1.
4
Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.VCA IgG、VCA IgM和EBNA-1抗体呈阳性且疑似传染性单核细胞增多症患者中原发性与再激活型爱泼斯坦-巴尔病毒感染的患病率
J Clin Virol. 2007 Apr;38(4):292-7. doi: 10.1016/j.jcv.2007.01.006. Epub 2007 Mar 1.
5
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.多发性硬化症患者对EB病毒的体液免疫反应与MRI上的疾病活动相关。
Neurology. 2009 Jul 7;73(1):32-8. doi: 10.1212/WNL.0b013e3181aa29fe. Epub 2009 May 20.
6
Recombinant Epstein-Barr virus glycoprotein 350 as a serological antigen.重组 Epstein-Barr 病毒糖蛋白 350 作为血清学抗原。
J Virol Methods. 2020 Oct;284:113927. doi: 10.1016/j.jviromet.2020.113927. Epub 2020 Jul 7.
7
Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.系统性自身免疫性疾病中针对阶段特异性爱泼斯坦-巴尔病毒抗原的抗体水平升高揭示了一种共同的病理特征。
Scand J Clin Lab Invest. 2019 Feb-Apr;79(1-2):7-16. doi: 10.1080/00365513.2018.1550807. Epub 2019 Feb 6.
8
Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.评价 Abbott Architect、Siemens Immulite、bioMerieux Vidas 和 Euroimmune 检测试剂盒用于 EB 病毒血清学诊断的性能。
J Med Virol. 2021 Nov;93(11):6309-6316. doi: 10.1002/jmv.27262. Epub 2021 Aug 17.
9
Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.EBV-IgG抗VCA亲和力的测定有助于原发性EBV感染的早期可靠诊断。
J Med Virol. 2003 Aug;70(4):617-23. doi: 10.1002/jmv.10439.
10
Differences in the Epstein-Barr Virus gp350 IgA Antibody Response Are Associated With Increased Risk for Coinfection With a Second Strain of Epstein-Barr Virus.EB 病毒 gp350 IgA 抗体反应的差异与感染第二种 EBV 病毒的风险增加有关。
J Infect Dis. 2019 Feb 23;219(6):955-963. doi: 10.1093/infdis/jiy601.

引用本文的文献

1
Use of bidirectional Mendelian randomization to unveil the association between antibody-mediated immune responses to infectious agents and allergic rhinitis.使用双向孟德尔随机化揭示针对感染因子的抗体介导免疫反应与变应性鼻炎之间的关联。
Hum Vaccin Immunother. 2025 Dec;21(1):2523090. doi: 10.1080/21645515.2025.2523090. Epub 2025 Jul 8.
2
SFRP2 mediates Epstein-Barr virus and bladder cancer risk: a Mendelian randomization study and colocalization analysis.分泌型卷曲相关蛋白2介导爱泼斯坦-巴尔病毒与膀胱癌风险:一项孟德尔随机化研究和共定位分析
Sci Rep. 2025 Feb 28;15(1):7118. doi: 10.1038/s41598-025-91594-9.
3
Genetic evidence identifies a causal relationship between EBV infection and multiple myeloma risk.

本文引用的文献

1
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.纵向分析显示,多发性硬化症与 Epstein-Barr 病毒的高患病率相关。
Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.
2
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases.爱泼斯坦-巴尔病毒:用于 EBV 相关疾病的疫苗和免疫细胞治疗的开发。
Front Immunol. 2021 Oct 8;12:734471. doi: 10.3389/fimmu.2021.734471. eCollection 2021.
3
Epstein Barr Virus and Autoimmune Responses in Systemic Lupus Erythematosus.
基因证据表明EB病毒感染与多发性骨髓瘤风险之间存在因果关系。
Sci Rep. 2025 Feb 21;15(1):6357. doi: 10.1038/s41598-025-90479-1.
4
Antibody Responses to EBV and Toxoplasma and Their Genetic Links to Guillain-Barré Syndrome: A Mendelian Randomization Study.针对EB病毒和弓形虫的抗体反应及其与吉兰-巴雷综合征的遗传联系:一项孟德尔随机化研究
Brain Behav. 2025 Feb;15(2):e70298. doi: 10.1002/brb3.70298.
5
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis.对多发性硬化症患者血清中针对爱泼斯坦-巴尔病毒生命周期蛋白、EBNA1、ANO2、胶质细胞粘附分子和CRYAB肽的抗体进行深入分析。
Front Immunol. 2024 Dec 17;15:1487523. doi: 10.3389/fimmu.2024.1487523. eCollection 2024.
6
Longitudinal Analysis of Binding Antibody Levels Against 39 Human Adenovirus Types in Sera from 60 Regular Blood Donors from Greifswald, Germany, over 5 Years from 2018 to 2022.2018年至2022年的5年间,对德国格赖夫斯瓦尔德60名定期献血者血清中针对39种人类腺病毒类型的结合抗体水平进行纵向分析。
Viruses. 2024 Nov 7;16(11):1747. doi: 10.3390/v16111747.
7
MENSA, a Media Enriched with Newly Synthesized Antibodies, to Identify SARS-CoV-2 Persistence and Latent Viral Reactivation in Long-COVID.MENSA,一种富含新合成抗体的介质,用于识别长期新冠患者中SARS-CoV-2的持续存在和潜伏病毒再激活。
medRxiv. 2024 Jul 7:2024.07.05.24310017. doi: 10.1101/2024.07.05.24310017.
8
Infectious mononucleosis in children and differences in biomarker levels and other features between disease caused by Epstein-Barr virus and other pathogens: a single-center retrospective study in China.儿童传染性单核细胞增多症及由 EBV 与其他病原体所致疾病在生物标志物水平及其他特征方面的差异:中国单中心回顾性研究。
PeerJ. 2023 Apr 6;11:e15071. doi: 10.7717/peerj.15071. eCollection 2023.
9
The Role of NK Cells in EBV Infection and Related Diseases: Current Understanding and Hints for Novel Therapies.自然杀伤细胞在EB病毒感染及相关疾病中的作用:当前认识与新型治疗策略提示
Cancers (Basel). 2023 Mar 22;15(6):1914. doi: 10.3390/cancers15061914.
10
Chronic viral coinfections differentially affect the likelihood of developing long COVID.慢性病毒合并感染会对长新冠的发病概率产生不同影响。
J Clin Invest. 2023 Feb 1;133(3):e163669. doi: 10.1172/JCI163669.
EB 病毒与系统性红斑狼疮中的自身免疫反应。
Front Immunol. 2021 Feb 3;11:623944. doi: 10.3389/fimmu.2020.623944. eCollection 2020.
4
Epstein-Barr Virus and Systemic Autoimmune Diseases.EB 病毒与系统性自身免疫性疾病。
Front Immunol. 2021 Jan 7;11:587380. doi: 10.3389/fimmu.2020.587380. eCollection 2020.
5
Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality.体液功能受损与 SARS-CoV-2 死亡率相关。
Cell. 2020 Dec 10;183(6):1508-1519.e12. doi: 10.1016/j.cell.2020.10.052. Epub 2020 Nov 3.
6
Maternal Epstein-Barr Virus-Specific Antibodies and Risk of Infection in Ugandan Infants.母亲的 Epstein-Barr 病毒特异性抗体与乌干达婴儿感染风险的关系。
J Infect Dis. 2021 Jun 4;223(11):1897-1904. doi: 10.1093/infdis/jiaa654.
7
Tracking the Trajectory of Functional Humoral Immune Responses Following Acute HIV Infection.追踪急性 HIV 感染后功能性体液免疫反应的轨迹。
Front Immunol. 2020 Aug 7;11:1744. doi: 10.3389/fimmu.2020.01744. eCollection 2020.
8
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens.麻疹病毒感染会削弱提供针对其他病原体保护的预先存在的抗体。
Science. 2019 Nov 1;366(6465):599-606. doi: 10.1126/science.aay6485.
9
Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents for mapping immunodominant epitopes.鉴定针对 Epstein-Barr 病毒 gp350 蛋白的多种具有潜在临床应用和作为免疫显性表位作图试剂的强效中和和非中和抗体。
Virology. 2019 Oct;536:1-15. doi: 10.1016/j.virol.2019.07.026. Epub 2019 Jul 30.
10
A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation.一种高通量、基于珠粒的抗原特异性测定法,用于评估抗体诱导补体激活的能力。
J Immunol Methods. 2019 Oct;473:112630. doi: 10.1016/j.jim.2019.07.002. Epub 2019 Jul 10.